Kesimpta® (ofatumumab)
for Multiple Sclerosis

Kesimpta (ofatumumab) is an FDA-approved medicine for relapsing forms of multiple sclerosis (MS). Kesimpta works by binding to CD20 on B cells, a type of immune cell, reducing their numbers and slowing MS progression. While it does not cure MS, clinical trials show it helps reduce relapses and slow disease progression. Kesimpta is a CD20 monoclonal antibody and selective immunosuppressant.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Multiple Sclerosis - MS